Barsoum R S. Chronic kidney disease in the developing world[J]. N Engl J Med,2006,354:997.
[2]
Vidt D G. Inflammation in renal disease[J]. Am J Cardiol,2006,97:20A.
[3]
Stenvinkel P. The role of inflammation in the anaemia of end-stage renal disease[J]. Nephrol Dial Transplant,2001,7:36.
[4]
Papayianni A. Cytokines,growth factors and other inflammatory mediators in glomerulonephritis[J]. Ren Fail,1996,18:725.
[5]
Han J,Jing Y,Li Z,et al. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation[J]. Nature,1997,386:296.
[6]
Sanz A B,Sanchez-Nino M D,Ramos A M,et al. NF-kappaB in renal inflammation[J]. J Am Soc Nephrol,2010,21:1254.
[7]
Cuadrado A,Nebreda A R. Mechanisms and functions of p38 MAPK signalling[J]. Biochem J,2010,429:403.
[8]
Cuenda A,Rousseau S. p38 MAP-Kinases pathway regulation,function and role in human diseases[J]. Biochim Biophys Acta,2007,1773:1358.
[9]
Ono K,Han J H. The p38 signal transduction pathway activation and function[J]. Cell Signal,2000,12:1.
[10]
Tian W,Zhang Z,Cohen D M. MAPK signalling and the kidney[J]. Am J Physiol Renal Physiol,2000,279:593.
[11]
Enslen H,Raingeaud J,Davis R J. Selective activation of p38 mitogen activated protein(MAP)kinase isoforms by the MAP kinase kinases MKK3 and MKK6[J]. J Biol Chem,1998,273:1741.
[12]
Chin B Y,Mohsenin A,Li S X,et al. Stimulation of pro-α1(I)colagen by TGF-β1 in mesangial cells:role of the p38MAPK pathway[J]. Am J Physiol Renal Physiol,2001,280:F495.
[13]
Gruden G,Zonca S,Hayward A,et al. Mechanical stretch-induced fibronectin and transforming growth factor-β1 production in human mesangial cells is p38 mitogen-activated protein kinase dependent[J]. Diabetes,2000,49:655.
[14]
Stambe C,Nikolic-Paterson D J,Hill P A,et al. p38 mitogen-activated protein kinase activation and cell localization in human glomerulonephritis:correlation with renal injury[J]. J Am Soc Nephrol,2004,15:326.
Isaka Y,Fujiwara Y,Ueda N,et al. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney[J]. J Clin Invest,1993,92:2597.
[20]
Border W A,Noble N A,Yamamoto T,et al. Nayural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease[J]. Nature,1992,360:361.
[21]
Wan Y,Gu L,Suzuki K,et al. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1. 1 monoclonal antibody[J]. Nephron Exp Nephrol,2005,99:e121.
Wang J P,Huang H Q,Liu P Q,et al. Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats[J]. Eur J Pharmacol,2006,553:297.
[25]
Liu W H,Tang F T,Deng Y H,et al. Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition[J]. Mol Cell Biochem,2009,325:99.
[26]
Ma F Y,Sachchithananthan M,Flanc R S,et al. Mitogen activated protein kinases in renal fibrosis[J]. Front Biosci,2009,1:171.
Zhang Y W,Xie D,Xia B,et al. Suppression of transforming growth factor-beta1 gene expression by Danggui Buxue Tang,a traditional Chinese herbal preparation,in retarding the progress of renal damage in streptozotocin-induced diabetic rats[J]. Horm Metab Res,2006,38:82.
[29]
Xu H Q,Hao H P. Effects of iridoid total glycoside from cornus officinalison prevention of glomerular overexpression of transforming growth factor beta1 and matrixes in an experimental diabetes model[J]. Biol Pharm Bull,2004,27:1014.
